Digital health technology in clinical trials

被引:14
|
作者
Mittermaier, Mirja [1 ,2 ,3 ,4 ]
Venkatesh, Kaushik P. [5 ]
Kvedar, Joseph C. [5 ]
机构
[1] Charite Univ Med Berlin, Dept Infect Dis Resp Med & Crit Care, Berlin, Germany
[2] Free Univ Berlin, Berlin, Germany
[3] Humboldt Univ, Berlin, Germany
[4] Charite Univ Med Berlin, Berlin Inst Hlth, Charitepl 1, D-10117 Berlin, Germany
[5] Harvard Med Sch, Boston, MA USA
关键词
Compendex;
D O I
10.1038/s41746-023-00841-8
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Digital health technologies (DHTs) have brought several significant improvements to clinical trials, enabling real-world data collection outside of the traditional clinical context and more patient-centered approaches. DHTs, such as wearables, allow the collection of unique personal data at home over a long period. But DHTs also bring challenges, such as digital endpoint harmonization and disadvantaging populations already experiencing the digital divide. A recent study explored the growth trends and implications of established and novel DHTs in neurology trials over the past decade. Here, we discuss the benefits and future challenges of DHT usage in clinical trials.
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Clinical trials in mental health
    Dunn, Graham
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2010, 19 (03) : 203 - 204
  • [42] Health disparity in digital health technology design
    Wu, Yanting
    Li, Yawen
    Baskys, Andrius
    Chok, Jay
    Hoffman, Janice
    Roosan, Don
    HEALTH AND TECHNOLOGY, 2024, 14 (02) : 239 - 249
  • [43] Health disparity in digital health technology design
    Yanting Wu
    Yawen Li
    Andrius Baskys
    Jay Chok
    Janice Hoffman
    Don Roosan
    Health and Technology, 2024, 14 : 239 - 249
  • [44] Digital technology, population health, and health equity
    James Chauvin
    Laetitia Rispel
    Journal of Public Health Policy, 2016, 37 : 145 - 153
  • [45] Digital technology, population health, and health equity
    Chauvin, James
    Rispel, Laetitia
    JOURNAL OF PUBLIC HEALTH POLICY, 2016, 37 : S145 - S153
  • [46] Do NIHR health technology assessment randomised clinical trials perform as well as expected?
    Amanda Young
    James Raftery
    Louise Stanton
    Andrew Cook
    Trials, 14 (Suppl 1)
  • [47] TREATMENT SWITCHING PROBLEM IN CANCER CLINICAL TRIALS -IMPLICATIONS FOR HEALTH TECHNOLOGY APPRAISAL OUTCOMES
    Panasiuk, A.
    Homa, M.
    Pawlik, D.
    Przda-Machno, P.
    Kaczor, M. P.
    VALUE IN HEALTH, 2016, 19 (07) : A758 - A758
  • [48] The Heartline Experience: Can Digital Health Technology Trials Achieve Long-Term Participant Engagement?
    Nikolovski, Janeta
    Navar, Ann Marie
    Steinhubl, Steve
    Baca-Motes, Katie
    Curtis, Anne B.
    Peterson, Eric D.
    Lakkireddy, Dhanunjaya
    Tarino, Michael
    Juan, Stephanie
    Damaraju, C. V.
    Wentworth, Dereck
    CIRCULATION, 2023, 148
  • [49] Digitalizing health trials by the Clinical Trials Transformation Initiative
    Goldhahn, Joerg
    Brasier, Noe
    Kehoe, Lindsay
    NATURE REVIEWS BIOENGINEERING, 2024, 2 (09): : 717 - 718
  • [50] Patient perspectives on digital healthcare technology in care and clinical trials for motor neuron disease: an international survey
    Jochem Helleman
    Barbara Johnson
    Cory Holdom
    Esther Hobson
    Deirdre Murray
    Frederik J. Steyn
    Shyuan T. Ngo
    Anjali Henders
    Madhura B. Lokeshappa
    Johanna M. A. Visser-Meily
    Leonard H. van den Berg
    Orla Hardiman
    Anita Beelen
    Chris McDermott
    Ruben P. A. van Eijk
    Journal of Neurology, 2022, 269 : 6003 - 6013